Web Exclusives

The year’s legal decisions affecting the pharma industry

Legal implications of sensitive data falling victim to a cyber-attack within the healthcare industry

How tech-enabled patient autonomy can ease the healthcare burden

The impending alterations to how pharma will engage with contractors may not be at the top of to do lists – but it should be, says Charlie Cox

Siera Torontow considers pharma’s success in dealing with ESG (Environmental, Social and Governance) issues and the impact on reputation

A closer working relationship for pharma reps and healthcare professionals (HCPs)

Partnerships to boost clinical research in rare diseases

Is personalised direct to consumer healthcare a threat or an opportunity for the pharma establishment?

A new wave of innovation is tackling antibiotic resistance

How robots will help shape the look of the pharmaceutical industry in 2021

How can pharma help drive COVID-19 vaccination adherence?

Beyond serialisation – the use of on-dose authentication to protect patients and brands from the rising threat of counterfeit drugs

The need to implement rigorous post-authorisation monitoring programmes as an added safety net for COVID-19 vaccines

Why combining expertise from the NHS and pharmaceutical experts will deliver better patient outcomes

The security of our medicines supply chain matters